Tandem Diabetes Care (TNDM) Raw Materials (2014 - 2019)

Tandem Diabetes Care has reported Raw Materials for 6 years, with the latest figure at $9.6 million in Q1 2019.

• For the quarter ending Q1 2019, Raw Materials fell 7.79% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2019 stood at $9.6 million (down 7.79% YoY), and the FY2018 full-year result was $6.6 million, down 35.88% from the prior year.
• Raw Materials for Q1 2019 stood at $9.6 million, up from $6.6 million in the prior quarter.
• The five-year high for Raw Materials was $12.1 million in Q2 2016, with the low at $6.6 million in Q4 2018.
• Historically, Raw Materials has averaged $9.9 million across 5 years, with a median of $10.0 million in 2016.
• Annual changes were most pronounced in 2015 — Raw Materials jumped 49.7% — and 2018, when it plunged 35.88%.
• Tandem Diabetes Care's Raw Materials stood at $10.6 million in 2015, then slipped by 11.61% to $9.4 million in 2016, then advanced by 10.17% to $10.3 million in 2017, then sank by 35.88% to $6.6 million in 2018, then surged by 44.74% to $9.6 million in 2019.
• The last three Raw Materials figures came in at $9.6 million (Q1 2019), $6.6 million (Q4 2018), and $8.6 million (Q3 2018), per Business Quant data.